1-[[4-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]phenyl]methyl]-4-methyl-3H-pyrido[2,3-b]pyrazin-2-one
C45H54FN9O4 — CID 171918781
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[4-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]phenyl]methyl]-4-methyl-3H-pyrido[2,3-b]pyrazin-2-one
1-[[4-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]phenyl]methyl]-4-methyl-3H-pyrido[2,3-b]pyrazin-2-one (PubChem CID 171918781) has the molecular formula C45H54FN9O4 and a molecular weight of 803.98 g/mol. Its IUPAC name is 1-[[4-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]phenyl]methyl]-4-methyl-3H-pyrido[2,3-b]pyrazin-2-one.
Molecular Properties
| Compound Name | 1-[[4-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]phenyl]methyl]-4-methyl-3H-pyrido[2,3-b]pyrazin-2-one |
|---|---|
| PubChem CID | 171918781 |
| Molecular Formula | C45H54FN9O4 |
| Molecular Weight | 803.98 g/mol |
| Exact Mass | 803.43 |
| IUPAC Name | 1-[[4-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]phenyl]methyl]-4-methyl-3H-pyrido[2,3-b]pyrazin-2-one |
| SMILES | CC1C(F)CC2NNCC2C1c1c(C2CC2)cc2c(N3C[C@@H]4C[C@H]3CN4)nc(OC3CCOCC3)nc2c1OCc1ccc(CN2C(=O)CN(C)c3ncccc32)cc1 |
| InChI | InChI=1S/C45H54FN9O4/c1-25-35(46)18-36-34(20-49-52-36)39(25)40-32(28-9-10-28)17-33-41(50-45(59-31-11-14-57-15-12-31)51-43(33)54-22-29-16-30(54)19-48-29)42(40)58-24-27-7-5-26(6-8-27)21-55-37-4-3-13-47-44(37)53(2)23-38(55)56/h3-8,13,17,25,28-31,34-36,39,48-49,52H,9-12,14-16,18-24H2,1-2H3/t25?,29-,30-,34?,35?,36?,39?/m0/s1 |
| InChIKey | LAUVEYQLZGLLEV-AURMFSSKSA-N |
| XLogP | 5.13 |
| TPSA | 129.24 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 803.98 |
| LogP ≤ 5 | 5.13 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171918781 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.